<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
Report by issuer of securities quoted on The Nasdaq Stock Market,
Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
and Rule 13a-17 or 15d-17 thereunder
THERATECH, INC.
--------------------------------------------
(Exact name of issuer as specified in charter)
417 WAKARA WAY, SALT LAKE CITY UTAH 84108
-----------------------------------------
(Address of principal executive officers)
Issuer's telephone number, including area code (801) 588-6200
---------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of shares
outstanding:
1. Title of security: Common Stock
--------------------------------------------------------
2. Number of shares outstanding before the change 13,510,296
----------------------------
3. Number of shares outstanding after the change 20,265,425
----------------------------
4. Effective date of change: June 28, 1996
-------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.) Stock Split
-----------
Give brief description of transaction: Three for two stock split
------------------------------------
---------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
------------------------------------------------------
2. Name after change
---------------------------------------------------------
3. Effective date of charter amendment changing name
-------------------------
4. Date of stockholder approval of change, if required
-----------------------
Date July 3, 1996 By Alexander L. Searl
----------------- -------------------------------------------------
Senior Vice President and Chief Financial Officer
